VITAMIN SHOPPE INC (VSI) Stock News
NYSE:VSI - New York Stock Exchange, Inc. -
VSI Latest News, Press Relases and Analysis
Franchise Group Results Slide as Firm Looks for Ways to Cut Debt
Franchise Group Inc., the firm at the center of a controversy surrounding B. Riley Financial Inc.’s finances, posted steep drops in first-quarter results as it grapples with looming maturities on its debt load, according to people familiar with the matter.
The Vitamin Shoppe® Partners with Alani Nu® for National Launch in Over 720 Stores and Online, Including Exclusive Protein and Pre-Workout Flavors
Targeting the modern, active woman, Alani Nu supplements are now available on vitaminshoppe.com and at all locations of The Vitamin Shoppe and Super Supplements
The Vitamin Shoppe names new CFO
The Vitamin Shoppe (VSI) has appointed Laura Coffey as Executive Vice President, Chief Financial Officer.During a 23-year career at Pier 1 Imports, Ms.
The Vitamin Shoppe® Appoints Muriel F. Gonzalez as EVP, Chief Merchandising and Marketing Officer
Senior merchant with deep expertise across omnichannel retail will drive merchandising, marketing, product development, and private brands strategy to evolve and elevate The Vitamin Shoppe customer experience
Mentions: FRG
Choice Hotels International Set to Join S&P MidCap 400 and Plantronics to Join S&P SmallCap 600
Choice Hotels +4% amid move to MidCap 400
Choice Hotels (NYSE:CHH) is up 4% after hours following news that it's moving into the S&P MidCap 400 index. It's making that move to replace Plantronics (NYSE:PLT), which is moving down into the
The Vitamin Shoppe Launches Holiday Campaign to Support Vitamin Angels' Life-Changing Mission
Vitamin Shoppe (VSI) Reports Break-Even Earnings for Q3
Vitamin Shoppe (VSI) delivered earnings and revenue surprises of -100.00% and -1.96%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Vitamin Shoppe, Inc. Announces Third Quarter 2019 Results
Vitamin Shoppe, Inc. Announces Third Quarter 2019 Results
Vitamin Shoppe (VSI) Earnings Expected to Grow: What to Know Ahead of Q3 Release
Vitamin Shoppe (VSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Newell Brands, AZZ, Synnex, Vitamin Shoppe and GMS
Zacks.com featured highlights include: Newell Brands, AZZ, Synnex, Vitamin Shoppe and GMS
5 Value Stocks With Alluring EV/EBITDA Ratios to Own Now
We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
Vitamin Shoppe unveils next-gen store concept
Vitamin Shoppe (VSI +0.3%) opens what it call an "innovation store" in Edgewater, New Jersey.The company says the concept brings a new vision to wellness retail, incorporating technology-drive
The Vitamin Shoppe Unveils New Innovation Retail Concept in Edgewater, New Jersey
Square (SQ Stock) Disrupts Yet Another Industry
Square (SQ stock) is a dream come true for small business owners. And that’s now true for a whole new (and red-hot) market: cannabidiol (CBD).
3 Value Investing ETFs Worth Considering
Three value investing ETFs worth considering now offer opportunities for exposure to small-cap stocks that have the potential to outperform large- and mid-cap funds. The three...
Charlotte’s Web Stock Turns Volatile This Week: What’s Coming Next?
It's been a volatile week for Charlotte's Web stock, but it's unclear why. With no announcement from Charlotte's Web Holdings, that can only mean one thing.
Best Stocks for 2019: Charlotte’s Web Stock Has Massive Potential
Charlotte's Web stock was caught in the general summer downtrend for cannabis stocks, but this CBD play has massive potential for the rest of 2019 and beyond.
The Correction Is a Solid Opportunity to Buy Hexo Stock
Earlier in the year, you would've needed a good psychiatrist if you purchased HEXO stock at its lofty levels. But now? Hexo is ripe for the picking.
58 Biggest Movers From Yesterday
Gainers Ovid Therapeutics Inc. (NASDAQ: OVID) shares climbed 25.5% to close at $3.10 on Tuesday. Citigroup raised the price target on Ovid Therapeutics from $8 to $10. Cellcom...
Vitamin Shoppe Shares See Unhealthy Decline After Merger Setback
Vitamin Shoppe will 'cease negotiations' with the bidder, Liberty Tax, 'in light of the failure of the bidder to obtain committed financing.'
Vitamin Shoppe -10% after potential higher buyout fizzles out
Vitamin Shoppe (NYSE:VSI) falls sharply after disclosing that it ended talks with an "unidentified" bidder during a go-shop period. The bidder failed to secure financing. Shares of VSI are do